The first day of the criminal fraud trial against Elizabeth Holmes focused on keeping COVID-19 and biased depictions of the famed Theranos founder out of the courtroom.

Holmes, whose trial kicked off on Tuesday in San Jose after several delays because of the COVID-19 pandemic and the birth of her first child, has been the subject of bestselling books, documentaries and a swell of media attention during the rise and demise of her defunct biotech company. In 2018, the government indicted Holmes amid allegations that she defrauded investors, doctors and patients about the efficacy of Theranos’ blood-testing technology.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]